Abstract. An effort was made to achieve different levels of plasma levonorgestrel (13-ethyl-17\g=a\-ethynyl-17\x=req-\ hydroxy-gon-4-en-3-one) (Ng) concentrations by the intra-uterine administration of levonorgestrel-releasing intra-uterine devices (IUD). Three .
designed to release different doses of Ng daily. Sixteen women volunteered for the study and had a Ng IUD inserted post-menstrually. The effect of the IUDs on the ovulatory pattern was studied by measuring plasma concentration of oestradiol and progesterone by radioimmunoassay. Ng plasma concentrations were also measured by radioimmunoassay. In vitro experiments to measure the release of Ng from each type of device were carried out. Although some overlapping of mean plasma levels of Ng occurred during use of the three models of the IUDs, suppression of ovulation was clearly dosedependent. Wide variations in plasma levels of Ng were seen between individuals but quite uniform plasma levels were seen in each subject for up to one year3. IUDs where in vitro release rates were equivalent to each other also resulted in wide individual variations in plasma concentrations of Ng.
In the mid-1960s Folkman & Long (1964a,b) and Dzuik & Cook (1966) (1968) . Clinical trials with intra-uterine devices releasing synthetic progestins (Home et al. 1970; Stryker et al. 1972) and natural progesterone (Scommegna et al. 1970; Pharriss et al. 1974) have since been performed. None of the reports have to our knowledge con¬ tained any data on the relationship between the intra-uterine release rate and the plasma concen¬ tration of the progestin used. In our early devel¬ opmental work on a levonorgestrel-releasing IUD we found that levonorgestrel (Ng) could be de¬ tected in the plasma of peripheral blood after the IUD was introduced into the uterine cavity (Nilsson et al. 1975) . We have also found that ovulation could be suppressed by the intra-uterine admini¬ stration of the steroid (Nilsson et al. 1976 ). The contraceptive effect of Ng-releasing IUDs was maintained (Luukkainen & Nilsson 1978) even when Ng plasma concentrations were not high enough to suppresss ovulation (Nilsson & Luukkai¬ nen 1977) . The mode of action appeared to be mainly local and based at least partly upon endometrial suppression .
In the present study, an effort was made to achieve different levels of plasma Ng concentra¬ tions by the intra-uterine administration of Ng with IUDs. These were designed to release different doses of Ng daily, and we endeavoured to study the effect of the IUDs on the ovulatory pattern of these subjects.
Materials and Methods
Sixteen healthy, regularly menstruating women between 22 and 38 years of age volunteered for the study. They all had a levonorgestrel-releasing IUD inserted immedia¬ tely post-menstrually.
The IUDs previously reported (Nilsson et Oestradiol and progesterone were measured by radioimmunoassays as described previously (Lähteenmäki 1978) . Plasma levonorgestrel concentrations were also determined by radioimmunoassay as described by Stanczyk et al. (1975) . Lyophilized rabbit levonorgestrel-3-CMO-BSA antiserum was kindly donated by Schering AG, Berlin, Germany. The sensitivity of the assay was 10 pg/ml, but due to a small plasma blank, the practical detection limit was 25 pg/ml. The intra-and inter-assay coefficients of variation, estimated according to Abraham et al. (1971) pg/ml for the 6 subjects during the first 90 days to a mean of 114 ±9 pg/ml for the three subjects sampled at one year. However, with so few data at the longer interval, judgement of the significance of this apparent decline is impossible. 
